Laboratory research materials for in vitro use only.

Cerebrolysin

For laboratory research use only (in vitro). Not for human or animal use.

$120.99

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$120.99
3-4 units5% off$114.94
5-9 units10% off$108.89
10+ units Best Value15% off$102.84

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

InteracVisaMCCrypto

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence Complex mixture of neuropeptide fragments (<10 kDa) derived from porcine brain proteins
Molecular Weight 10000 Da
Molecular Formula Complex mixture
CAS Number 12656-61-0
Purity ≥98% (HPLC)
Format Lyophilized Powder
Net Quantity 60mg
Vials Per Kit 6
Storage Store at -20C. Reconstituted: 2-8C
Research Status Approved

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

Cerebrolysin analytical reference compound. Molecular weight 10000 Da.

Specifications

Sequence Complex mixture of neuropeptide fragments (<10 kDa) derived from porcine brain proteins
Molecular Weight 10000 Da
Molecular Formula Complex mixture
CAS 12656-61-0
Purity >=98% (HPLC)
Format Lyophilized powder
Storage Store at -20C. Reconstituted: 2-8C

For laboratory research use only (in vitro). Not for human or animal use.

Published Research

5 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Cerebrolysin in Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial (CASTA)

Heiss WD, Brainin M, Bornstein NM, et al. (2012). Stroke. PubMed 22282884

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Double-Blind, Placebo-Controlled Trial

Muresanu DF, Heiss WD, Hoemberg V, et al. (2016). Stroke. PubMed 26564102

Cerebrolysin in Mild to Moderate Alzheimer's Disease: A 28-Week Randomized Controlled Trial

Alvarez XA, Cacabelos R, Laredo M, et al. (2006). European Journal of Neurology. PubMed 16420392

Cerebrolysin for Acute Ischaemic Stroke (Cochrane Review)

Ziganshina LE, Abakumova T, Vernay L (2020). Cochrane Database of Systematic Reviews. PubMed 32657407

Cerebrolysin as Acute Post-Traumatic Adjunctive Intervention (CAPTAIN Trial)

Chen CC, Wei ST, Tsaia SC, et al. (2013). British Journal of Neurosurgery. DOI

For laboratory research use only (in vitro). Not for human or animal use.

Age Verification Required

You must be 19 years of age or older to access this website. This site contains laboratory research materials restricted to qualified personnel.